[1]王娟娟,成官迅,马 捷.乳腺导管原位癌的影像学及分子生物学特点与临床决策的相关性研究[J].医学信息,2022,35(16):150-154.[doi:10.3969/j.issn.1006-1959.2022.16.039]
 WANG Juan-juan,CHENG Guan-xun,MA Jie.Correlation Between Imaging and Molecular Biological Characteristics of Breast Ductal Carcinoma In Situ and Clinical Decision-making[J].Journal of Medical Information,2022,35(16):150-154.[doi:10.3969/j.issn.1006-1959.2022.16.039]
点击复制

乳腺导管原位癌的影像学及分子生物学特点与临床决策的相关性研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年16期
页码:
150-154
栏目:
综述
出版日期:
2022-08-15

文章信息/Info

Title:
Correlation Between Imaging and Molecular Biological Characteristics of Breast Ductal Carcinoma In Situ and Clinical Decision-making
文章编号:
1006-1959(2022)16-0150-05
作者:
王娟娟成官迅马 捷
(1.汕头大学医学院,广东 汕头 515000;2.深圳市人民医院放射科,广东 深圳 518000;3.北京大学深圳医院医学影像科,广东 深圳 518000)
Author(s):
WANG Juan-juanCHENG Guan-xunMA Jie
(1.Medical College of Shantou University,Shantou 515000,Guangdong,China;2.Department of Radiology,Shenzhen People’s Hospital,Shenzhen 518000,Guangdong,China;3.Department of Medical Imaging,Shenzhen Hospital,Peking University,Shenzhen 518000,Guangdong,China)
关键词:
乳腺导管原位癌导管原位癌伴微浸润浸润性导管癌
Keywords:
Ductal carcinoma in situDuctal carcinoma in situ with microinvasionInvasive ductal carcinoma
分类号:
R737.9
DOI:
10.3969/j.issn.1006-1959.2022.16.039
文献标志码:
A
摘要:
乳腺导管原位癌(DCIS)被认为是一种可以治愈的早期癌症,其中一些导管原位癌被认为是具有向浸润性导管癌(IDC)发展的潜能。DCIS伴微浸润(DCIS-Mi)被认为是DCIS向IDC发展的过渡阶段,而IDC的治疗、预后复发及生存率与DCIS完全不同,故对DCIS的早期诊治非常有必要。本文主要就乳腺导管原位癌的影像学特征、病理分子生物学标记物及其临床治疗预后的相关性进行综述,旨在从影像学角度认识导管原位癌的生物学行为。
Abstract:
Ductal carcinoma in situ (DCIS) is considered to be a curable early cancer, some of which are considered to have the potential to develop into invasive ductal carcinoma (IDC). DCIS with microinvasion (DCIS-Mi) is considered to be a transitional stage from DCIS to IDC, and the treatment, prognosis, recurrence and survival rate of IDC are completely different from those of DCIS, so it is necessary to diagnose and treat DCIS early. This article reviews the imaging features, pathological molecular biological markers and their correlation with clinical treatment and prognosis of ductal carcinoma in situ, aiming to understand the biological behavior of ductal carcinoma in situ from the perspective of imaging.

参考文献/References:

[1]DeSantis CE,Ma J,Gaudet MM,et al.Breast cancer statistics,2019[J].CA Cancer J Clin,2019,69(6):438-451.[2]Koh VCY,Lim JCT,Thike AA,et al.Behaviour and characteristics of low-grade ductal carcinoma in situ of the breast:literature review and single-centre retrospective series[J].Histopathology,2019,74(7):970-987.[3]Zheng J,Zhou T,Li F,et al.Clinic-pathological features of breast ductal carcinoma in situ with micro-invasion[J].Cancer Invest,2020,38(2):113-121.[4]Liu BT,Ding JN,Wang JL,et al.Differences in pathologic characteristics between ductal carcinoma in situ (DCIS),DCIS with microinvasion and DCIS with invasive ductal carcinoma[J].International Journal of Clinical and Experimental Pathology,2020,13(5):1066-1072.[5]Murthy V,Chamberlain RS.Nipple-sparing mastectomy in modern breast practice[J].Clinical Anatomy,2013,26(1):56-65.[6]Silverstein MJ,Poller DN,Waisman JR,et al.Prognostic classification of breast ductal carcinoma-in-situ[J].Lancet,1995,345:1154-1157.[7]孙琳,孙晓枫,王卉,等.超声及钼靶X线对乳腺导管内癌与乳腺浸润性导管癌的诊断价值[J].现代肿瘤医学,2019,27(22):4089-4093.[8]段克举,杨亚芳,刘真真.钙化型及非钙化型乳腺导管原位癌的病理分级及免疫组织化学特征[J].临床放射学杂志,2021,1:42-47.[9]王祥芝.FFDM+DBT与MRI在乳腺良恶性疾病诊断中的对比应用[D].蚌埠:蚌埠医学院,2021.[10]Dromain C,Thibault F,Diekmann F,et al.Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study[J].Breast Cancer Research,2012,14(3):R94.[11]文婵娟,徐维敏,曾辉,等.对比增强X线摄影对乳腺可疑病变的诊断价值[J].中华放射学杂志,2019,53(9):737-741.[12]顾雅佳,王玖华, 涂小予,等.乳腺导管原位癌的钼靶X线表现与病理对照研究[J].中华放射学杂志,2002,36(3):240-244.[13]马发鹏,常宝,王时茂,等.乳腺导管原位癌X线特征与病理核分级及不同肿瘤因子表达相关性[J].放射学实践,2020,35(6):731-735.[14]王阿军.乳腺浸润性导管癌及原位癌超声特征与分子分型的关系分析[D].苏州:苏州大学,2018.[15]Scott-Moncrieff A,Sullivan ME,Mendelson EB,et al.MR imaging appearance of noncalcified and calcified DCIS[J].Breast J,2018,24(3):343-349. [16]吴朋,崔蕾,郭宏兵,等.DWI及DCE-MRI对乳腺纯导管原位癌,导管原位癌伴微浸润及浸润导管癌的鉴别诊断价值[J].放射学实践,2020,35(4):489-496.[17]Lehotska V,Rauova K,Vanovcanova L,et al.Multiparametric MRI analysis of morphologico-functional features of DCIS-correlation with the grade of nuclear atypia[J].Neoplasma,2018,65(3):389-397.[18]Tao WJ,Zhang HX,Zhang LM,et al.Combined application of pharamcokinetic DCE‐MRI and IVIM‐DWI could improve detection efficiency in early diagnosis of ductal carcinoma in situ[J].Journal of Applied Clinical Medical Physics,2019,20(7):142-150.[19]刘慧敏,曹小丽,刘瑞华,等.乳腺导管原位癌超声表现与病理关系的研究[J].中华实验外科杂志,2017,34(4):581-583.[20]Watanabe T,Yamaguchi T,Tsunoda H,et al.Ultrasound Image Classification of Ductal Carcinoma In Situ (DCIS) of the Breast:Analysis of 705 DCIS Lesions[J].Ultrasound Med Biol,2017,43(5):918-925.[21]Wang LC,Sullivan M,Du H,et al.US Appearance of Ductal Carcinoma in Situ[J].Radio Graphics,2013,33(1):213-228.[22]王知力,孙璐,胡亚卓,等.乳腺病变剪切波弹性模量与胶原纤维的相关性[J].中国医学影像学杂志,2014,22(10):721-724.[23]Bae JS,Chang JM,Lee SH,et al.Prediction of invasive breast cancer using shear-wave elastography in patients with biopsy-confirmed ductal carcinoma in situ[J].Eur Radiol,2017,27(1):7-15.[24]李玉双,胡中倩,叶新华,等.剪切波弹性成像对乳腺导管原位癌的诊断价值及漏诊的潜在因素[J].东南大学学报(医学版),2021,40(2):183-188.[25]任静,翁萍,吐尔逊纳依,等.乳腺导管内癌的病理特征与超声造影的相关性[J].实用医学杂志,2017,33(1):121-124.[26]杜睿,薛玉,张歆,等.乳腺浸润性导管癌与导管内癌的超声造影血流动力学对比研究[J].中华肿瘤防治杂志,2015,22(2):129-133.[27]陆海岚,李琳,吴鹏西,等.乳腺导管原位癌超声声像图特征与临床病理特征的相关性研究[J].中国现代医药杂志,2019,21(10):32-35.[28]Wang H,Lin J,Lai J,et al.Imaging features that distinguish pure ductal carcinoma in situ (DCIS) from DCIS with microinvasion[J].Molecular and Clinical Oncology,2019,11(3):313-319.[29]Yao JJ,Zhan WW,Chen M,et al.Sonographic features of ductal carcinoma in situ of the breast with microinvasion:correlation with clinicopathologic findings and biomarkers[J].J Ultrasound Med,2015,34(10):1761-1768.[30]Viani GA,Stefano EJ,Afonso SL,et al.Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials[J].Radiat Oncology,2007,2(1):28.[31]刘伟欣,王淑莲,宋永文,等.乳腺导管内原位癌治疗趋势和预后单中心分析[J].中华放射肿瘤学杂志,2019,28(2):96-101.[32]Rowland JH,Holland JC,Chaglassian T,et al.Psychological response to breast reconstruction. Expectations for and impact on postmastectomy functioning[J].Psychosomatics,1993,34(3):241-250.[33]Sagara Y,Freedman RA,Vaz-Luis I,et al.Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study[J].J Clin Oncol,2016,34(11):1190-1196.

相似文献/References:

[1]于 冰,冯 锐.乳腺导管原位癌外科手术治疗的研究进展[J].医学信息,2018,31(05):47.[doi:10.3969/j.issn.1006-1959.2018.05.017]
 YU Bing,FENG Rui.Progress in Surgical Treatment of Breast Ductal Carcinoma in Situ[J].Journal of Medical Information,2018,31(16):47.[doi:10.3969/j.issn.1006-1959.2018.05.017]
[2]韩 璐.乳腺导管原位癌外科手术治疗的研究[J].医学信息,2022,35(15):160.[doi:10.3969/j.issn.1006-1959.2022.15.038]
 HAN Lu.Study on Surgical Treatment of Ductal Carcinoma In Situ of the Breast[J].Journal of Medical Information,2022,35(16):160.[doi:10.3969/j.issn.1006-1959.2022.15.038]

更新日期/Last Update: 1900-01-01